H-Glu(OtBu)-OMe · HCl

H-Glu(OtBu)-OMe · HCl is a protected glutamic acid derivative presented as the hydrochloride salt, featuring an N-terminal benzyloxycarbonyl-type amino acid precursor motif and a C-terminal methyl ester (OMe) alongside a side-chain tert-butyl ester protecting group (OtBu) on the γ-carboxylate. The stereochemical integrity of the glutamate α-center is maintained as a chiral amino acid building block, while the salt form improves handling of the amine during synthesis and can influence coupling behavior under peptide coupling conditions. The molecule contains multiple carbonyl-bearing functional groups that participate in amide bond formation after appropriate activation, and the orthogonally protected carboxyl functionalities enable selective deprotection to access free glutamate for downstream peptide and conjugation chemistry. This structure is well-suited as a peptide synthesis intermediate and as a chiral platform for glutamate derivatization, including controlled side-chain functional group unveiling and subsequent synthetic elaboration.

1. Peptide Synthesis

H-Glu(OtBu)-OMe · HCl is used in peptide synthesis workflows where glutamate residues require orthogonal protection of the side-chain carboxyl group and a protected C-terminus to control chain growth. The N-terminal amino functionality and the methyl ester C-terminus support standard peptide coupling and subsequent transformations, while the OtBu-protected γ-carboxylate allows selective deprotection to regenerate the native glutamate side chain after assembly. The hydrochloride salt form can help maintain amine availability for coupling steps while minimizing undesired side reactions during intermediate handling. Resulting peptide products can incorporate glutamate in defined stereochemical form, enabling sequence-specific studies and the preparation of peptide building blocks for further functionalization.

2. Side-Chain Functionalization

H-Glu(OtBu)-OMe · HCl serves as a chiral precursor for glutamate side-chain functionalization in chemical biology and synthetic organic chemistry. The γ-carboxylate protected as OtBu provides a masked handle that can be selectively unmasked to generate a free side-chain carboxylic acid for further derivatization, including conversion to activated esters, amides, or other electrophile-compatible derivatives. The methyl ester functionality allows controlled downstream transformations toward C-terminal modifications, including switching to alternative ester or acid forms depending on the target scaffold. This protected glutamate architecture supports stepwise construction of functionalized amino acid analogs and peptidomimetic fragments that require precise placement of acidic functionality.

3. Protected Amino Acid Chemistry

H-Glu(OtBu)-OMe · HCl is applied as a protected amino acid intermediate for orthogonally protected glutamate chemistry where selective deprotection strategies are required. The combination of a side-chain OtBu ester and a C-terminal methyl ester provides a protection pattern that can be exploited to manage chemoselectivity during iterative synthesis, including staged unveiling of the γ-carboxyl group and adjustment of the terminal carboxyl state. The salt-associated amine can be advantageous for reproducible handling in fine chemical synthesis, particularly when preparing a series of glutamate-containing derivatives with consistent stereochemical configuration. Downstream use includes preparation of glutamate building blocks for peptide coupling, fragment assembly, and controlled generation of reactive glutamate forms for subsequent functional group installation.

4. Bioconjugation Chemistry

H-Glu(OtBu)-OMe · HCl can be incorporated into bioconjugation strategies that require glutamate-derived linkers with defined stereochemistry and protected reactive groups during synthetic staging. The protected γ-carboxylate enables synthesis of conjugation-ready intermediates without premature crosslinking, while the methyl ester and N-terminal functionality can be converted into coupling-compatible moieties after deprotection and activation. The resulting glutamate-containing conjugates can be used to introduce anionic spacing elements, modulate local charge distribution, or provide attachment points for biomolecule labeling workflows. This amino acid derivative thus supports the preparation of linker architectures for protein conjugates and other biomolecule-modification targets where controlled functional group presentation matters.

5. Pharmaceutical Intermediate Preparation

H-Glu(OtBu)-OMe · HCl is suitable for pharmaceutical intermediate preparation in process chemistry settings that require reproducible access to glutamate building blocks for peptide-like and peptidomimetic structures. The orthogonal protection pattern on the side-chain carboxyl group and the protected C-terminal ester can be aligned with route design that separates chain assembly from final functional group unveiling, supporting scalable synthesis of glutamate-containing intermediates. The hydrochloride salt form can aid in handling of the amino functionality during manufacturing steps that involve isolation and transfer between unit operations. Downstream intermediates derived from this compound can feed into the synthesis of complex, multi-functional molecules where glutamate stereochemistry and controlled carboxyl reactivity are required for consistent synthetic outcomes.

6. Analytical Standards And SAR Studies

H-Glu(OtBu)-OMe · HCl is used in analytical research contexts where protected glutamate standards and reference intermediates support method development and structure-confirming analyses. The defined presence of multiple carbonyl groups and the characteristic protection pattern (OtBu and methyl ester) can facilitate LC-MS or chromatographic differentiation of protected versus deprotected glutamate species during synthetic monitoring. The chiral amino acid backbone enables generation of stereochemically consistent analogs for structure-activity relationship studies involving glutamate-containing motifs or acidic side-chain presentations. This makes the compound relevant as a controlled intermediate for building and verifying SAR libraries that depend on precise glutamate functional group placement and protection-state management.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Implications of ligand-receptor binding kinetics on GLP-1R signalling

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore